Subgroup analysis in RE-MIND2: An observational, retrospective cohort study of tafasitamab + lenalidomide versus systemic therapies in patients with relapsed/refractory diffuse large B-cell lymphoma Meeting Abstract
| Authors: | Nowakowski, G.; Yoon, D. H.; Joffe, E.; Zinzani, P. L.; Sabatelli, L.; Waltl, E. E.; Alvero, C. G.; Hess, G.; Riedell, P.; Kim, K.; Brixner, D.; Salles, G. |
| Abstract Title: | Subgroup analysis in RE-MIND2: An observational, retrospective cohort study of tafasitamab + lenalidomide versus systemic therapies in patients with relapsed/refractory diffuse large B-cell lymphoma |
| Meeting Title: | 10th Annual Meeting of the Society of Hematologic Oncology (SOHO) |
| Keywords: | lenalidomide; dlbcl; real-world evidence; abcl; tafasitamab; re-mind2 |
| Journal Title: | Clinical Lymphoma, Myeloma and Leukemia |
| Volume: | 22 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2022 Sep 28-Oct 1 |
| Meeting Location: | Houston, TX |
| ISSN: | 2152-2650 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-10-01 |
| Start Page: | S359 |
| Language: | English |
| ACCESSION: | WOS:000897948100378 |
| PROVIDER: | wos |
| DOI: | 10.1016/s2152-2650(22)01499-9 |
| Notes: | Meeting Abstract: ABCL-088 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
